GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (STU:S1R) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Shanghai Pharmaceuticals Holding Co (STU:S1R) Future 3-5Y EPS without NRI Growth Rate : 14.95 (As of May. 17, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate is 14.95.

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Shanghai Pharmaceuticals Holding Co  (STU:S1R) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Shanghai Pharmaceuticals Holding Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (STU:S1R) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
SHSE:600332 SHSE:600998 SHSE:600511 SHSE:600739 SHSE:600056 SZSE:000028 SZSE:301015 SZSE:000950 SHSE:603368 SZSE:002589 MCK COR CAH ASX:SIG HSIC HKSE:01099 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459
Traded in Other Exchanges
SHPMY:USA SHPMF:USA 02607:Hong Kong 601607:China
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Website
https://www.sphchina.com
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines